| Literature DB >> 25882805 |
Carlos A Jiménez-Ruiz1, Stefan Andreas2, Keir E Lewis3, Philip Tonnesen4, C P van Schayck5, Peter Hajek6, Serena Tonstad7, Bertrand Dautzenberg8, Monica Fletcher9, Sarah Masefield10, Pippa Powell10, Thomas Hering11, Stefano Nardini12, Thomy Tonia13, Christina Gratziou14.
Abstract
Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary tuberculosis are common pulmonary diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with pulmonary diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking.This is a qualitative review regarding smoking cessation in patients with COPD and other pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches.Entities:
Mesh:
Year: 2015 PMID: 25882805 DOI: 10.1183/09031936.00092614
Source DB: PubMed Journal: Eur Respir J ISSN: 0903-1936 Impact factor: 16.671